Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 5OTHER 4NIH 2OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 107Neoplasms 80Colorectal Neoplasms 54Uterine Cervical Neoplasms 29Stomach Neoplasms 29Lung Neoplasms 27Rectal Neoplasms 25Prostatic Neoplasms 25Colonic Neoplasms 24Polycystic Ovary Syndrome 22Pancreatic Neoplasms 22Head and Neck Neoplasms 17Endometrial Neoplasms 17Carcinoma, Non-Small-Cell Lung 16Carcinoma, Hepatocellular 16Pain 15Neoplasm Metastasis 15Motor Activity 15Esophageal Neoplasms 15Ovarian Neoplasms 13Urinary Bladder Neoplasms 11Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Pain, Postoperative 10Melanoma 10Thyroid Neoplasms 9Pilonidal Sinus 9Multiple Myeloma 9Gastrointestinal Neoplasms 9Sarcopenia 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × OTHER_GOV × Camurati-Engelmann Syndrome × Clear all
NCT00686738 2016-03-23

Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients

National Cancer Center, Korea

Completed
20 enrolled
Sarcoma

Camurati-Engelmann Syndrome, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡